Sigara ile ilişkili ciddi akciğer hastalığı olanların sigara içen yakınlarında sigara bırakma tedavisinin başarısı
Küçük Resim Yok
Tarih
2002
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Sigara ile ilişkili ciddi akciğer hastalığı olanların sigara içen yakınlarının sigara bırakma programına alınması ve yakınında sigara ile ilişkili hastalık bulunmasının sigara bırakma başarısı üzerinde etkili olup olmadığı araştırılmıştır. Sigarayı bırakmak isteyen 34 hasta yakını (grup I) ve bu olguların programa alındığı süre içinde polikliniğe başvuran ve yakınlarında sigara ile ilişkili hastalık anamnezi olmayan ardışık 34 kontrol olgusu (grup II) çalışmaya alınmıştır. Her olgu, 1 yıl süre ile izlenmiş olup, 68 olgunun 37'si (%54.4) kadın, 31'i (%45.6) erkektir. Yaş ortalaması 46.08±9.16'dır (26-68) ve %40.6'sı lise, %42.2'si üniversite mezunudur. Grup I'de olguların %23.5'inin yakınında KOAH, %61.8'inin yakınında akciğer kanseri, %14.7'sinin yakınında ise hem KOAH hem de akciğer kanseri anamnezi vardır. Olguların %14.7'si hastalar ile aynı evde oturmaktadır. İki grup arasında sigaraya başlama yaşı, paket yılı, Fagerström Nikotin Bağımlılık Test Skoru açısından anlamlı farklılık yoktur (p>0.05). Nikotin replasman tedavisi, grup I'de 10 (%29.4), grup II'de ise 14 (%41.2) olguda uygulanmıştır. İlk görüşmede CO düzeyi 16.43±7.6 ppm iken 15. günde sigarayı bırakan olgularda 4.5±4.7 ppm, bırakamayan olgularda ise 13.0±1.5 ppm olarak bulunmuştur (p<0.01). On beşinci günde grup I'de olguların %79.4'ü, grup II'de %73.5'i, aynı sırayla 3. ayda %67.6 ve %64.7'si, 1. yıl sonunda %41.2 ve %38.2'si sigara içmemektedir (p>0.05). Olguların sigara bırakma programına alınması, düzenli izlem ve motivasyon desteği sağlanmasının sigarayı bırakma başarısını artırdığı, ancak yakınında sigara ile ilişkili hastalık bulunmasının sigarayı bırakma üzerinde etkili olmadığı sonucuna varılmıştır.
The aim of the study was to investigate the success of a smoking cessation program among the smoker relatives of patients with serious smoking-related lung disorders. A total of 68 smokers entered the study. Group I consisted of 34 relatives who wanted to quit smoking. Group II consisted of 34 control smokers with no history of a relative with a tobacco related serious disease. Each case was followed for a year. Out of a total of 68 cases 37 (54.4%) were female and 31 (45.6%) were male. The mean of age of the cases was 46.08±9.16 years (26-68 years) and of all cases, 40.6% were high school graduates and 42.2% were university graduates. In the first group, 23.5% of cases had a relative with COPD, 61.8% with lung cancer, and 14.7% with both COPD and lung cancer. Of these patients, 14.7% shared the same house with their relatives. When the age of smoking initiation, the number of cigarettes smoked per day, package-year and Fagerström Test for Nicotine Dependence Score were compared, there was no statistically important difference between the two groups. Nicotine replacement therapy was applied to 10 cases (29.4%) in the first group and 14 cases (41.2%) in the second group. The CO level was 16.43 ± 7.6 ppm (3-34) at the first appointment. On the 15th day it was found 4.5±4.7 ppm among the cases who quit smoking and 13.0±1.5 ppm among the cases who continued smoking. The rates of quitting were 79.4% and 73.5% at the 15th day, 67.6% and 64.7% at the third month and 41.2% and 38.2% at the first year, in the first and second groups, respectively. Smoking cessation program, regular follow-up and motivational support increased quitting rate however having a relative with a disease related with smoking does not influence smoking cessation.
The aim of the study was to investigate the success of a smoking cessation program among the smoker relatives of patients with serious smoking-related lung disorders. A total of 68 smokers entered the study. Group I consisted of 34 relatives who wanted to quit smoking. Group II consisted of 34 control smokers with no history of a relative with a tobacco related serious disease. Each case was followed for a year. Out of a total of 68 cases 37 (54.4%) were female and 31 (45.6%) were male. The mean of age of the cases was 46.08±9.16 years (26-68 years) and of all cases, 40.6% were high school graduates and 42.2% were university graduates. In the first group, 23.5% of cases had a relative with COPD, 61.8% with lung cancer, and 14.7% with both COPD and lung cancer. Of these patients, 14.7% shared the same house with their relatives. When the age of smoking initiation, the number of cigarettes smoked per day, package-year and Fagerström Test for Nicotine Dependence Score were compared, there was no statistically important difference between the two groups. Nicotine replacement therapy was applied to 10 cases (29.4%) in the first group and 14 cases (41.2%) in the second group. The CO level was 16.43 ± 7.6 ppm (3-34) at the first appointment. On the 15th day it was found 4.5±4.7 ppm among the cases who quit smoking and 13.0±1.5 ppm among the cases who continued smoking. The rates of quitting were 79.4% and 73.5% at the 15th day, 67.6% and 64.7% at the third month and 41.2% and 38.2% at the first year, in the first and second groups, respectively. Smoking cessation program, regular follow-up and motivational support increased quitting rate however having a relative with a disease related with smoking does not influence smoking cessation.
Açıklama
Anahtar Kelimeler
Kulak, Burun, Boğaz
Kaynak
Toraks Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
3
Sayı
3
